<ARTICLE> 5 <LEGEND> This schedule contains summary information extracted from the Statements of Operations and Balance Sheets of InVitro International and is qualified in its entirety by reference to such financial statements. </LEGEND> <CIK> 0000872610 <NAME> INVITRO INTERNATIONAL <MULTIPLIER> 1000 <FISCAL-YEAR-END> Sep-30-1996 <PERIOD-START> Oct-01-1995 <PERIOD-END> Mar-31-1996 <PERIOD-TYPE> 6-MOS <CASH> 1,239 <SECURITIES> 0 <RECEIVABLES> 203 <ALLOWANCES> 15 <INVENTORY> 188 <CURRENT-ASSETS> 170 <PP&E> 1,010 <DEPRECIATION> 764 <TOTAL-ASSETS> 2,113 <CURRENT-LIABILITIES> 309 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 23,864 <OTHER-SE> (22,060) <TOTAL-LIABILITY-AND-EQUITY> 2,113 <SALES> 485 <TOTAL-REVENUES> 485 <CGS> 333 <TOTAL-COSTS> 941 <OTHER-EXPENSES> (39) <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (989) <INCOME-TAX> 0 <INCOME-CONTINUING> (989) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (989) <EPS-PRIMARY> (0.08) <EPS-DILUTED> (0.08)